CL:0002620

Name:	skin fibroblast
Namespace:	FANTOM
Definition:	"A fibroblast of skin." [GOC:tfm]
Xrefs:	Expandlinks: BTO:0001255
Created by:	tmeehan
Creation date:	2011-03-14T12:31:49Z

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000057(fibroblast)
part_of:	UBERON:0002097(skin of body)

Children

is a:	CL:0002551 (fibroblast of dermis),FF:10600-108E6 (myxofibrosarcoma cell line:MFH-ino),FF:10684-109E9 (myxofibrosarcoma cell line:NMFH-1)
derives from:	FF:0000250 (human fibroblast of skin sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 10600-108E6 (myxofibrosarcoma cell line:MFH-ino)
• 10684-109E9 (myxofibrosarcoma cell line:NMFH-1)
• 11269-116G9 (Fibroblast - Dermal, donor1)
• 11346-117G5 (Fibroblast - Dermal, donor2)
• 11418-118F5 (Fibroblast - Dermal, donor3)
• 11450-119A1 (Fibroblast - Dermal, donor4)
• 11454-119A5 (Fibroblast - Dermal, donor5)
• 11458-119A9 (Fibroblast - Dermal, donor6)
• 11553-120C5 (Fibroblast - skin normal, donor1)
• 11554-120C6 (Fibroblast - skin walker warburg, donor1)

... further results Mouse (Mus musculus)

• 10600-108E6 (myxofibrosarcoma cell line:MFH-ino)
• 10684-109E9 (myxofibrosarcoma cell line:NMFH-1)
• 11269-116G9 (Fibroblast - Dermal, donor1)
• 11346-117G5 (Fibroblast - Dermal, donor2)
• 11418-118F5 (Fibroblast - Dermal, donor3)
• 11450-119A1 (Fibroblast - Dermal, donor4)
• 11454-119A5 (Fibroblast - Dermal, donor5)
• 11458-119A9 (Fibroblast - Dermal, donor6)
• 11553-120C5 (Fibroblast - skin normal, donor1)
• 11554-120C6 (Fibroblast - skin walker warburg, donor1)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0002620 (skin fibroblast), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
5.28e-79	FFCP PHASE1:Hg19::chr13:24044200..24044211,+	p2@LINC00327
5.28e-79	FFCP PHASE2:Hg19::chr13:24044200..24044211,+	p2@LINC00327
8.25e-75	FFCP PHASE2:Hg19::chr4:184271970..184271992,-	p@chr4:184271970..184271992, -
8.25e-75	FFCP PHASE1:Hg19::chr4:184271970..184271992,-	p@chr4:184271970..184271992, -
3.0e-69	FFCP PHASE2:Hg19::chr22:48819856..48819861,+	p@chr22:48819856..48819861, +
3.0e-69	FFCP PHASE1:Hg19::chr22:48819856..48819861,+	p@chr22:48819856..48819861, +
1.73e-68	FFCP PHASE1:Hg19::chr13:24044226..24044237,+	p1@LINC00327
1.73e-68	FFCP PHASE2:Hg19::chr13:24044226..24044237,+	p1@LINC00327
2.25e-64	FFCP PHASE2:Hg19::chr15:33180498..33180522,-	p4@FMN1
2.25e-64	FFCP PHASE1:Hg19::chr15:33180498..33180522,-	p4@FMN1
2.96e-62	FFCP PHASE1:Hg19::chr1:197886772..197886790,+	p4@LHX9
2.96e-62	FFCP PHASE2:Hg19::chr1:197886772..197886790,+	p4@LHX9
5.44e-61	FFCP PHASE2:Hg19::chr1:198636258..198636278,-	p1@ENST00000413577
5.44e-61	FFCP PHASE1:Hg19::chr1:198636258..198636278,-	p1@ENST00000413577
6.11e-60	FFCP PHASE1:Hg19::chr15:33180622..33180633,-	p13@FMN1
6.11e-60	FFCP PHASE2:Hg19::chr15:33180622..33180633,-	p13@FMN1
1.75e-59	FFCP PHASE1:Hg19::chr1:198636234..198636246,-	p2@ENST00000413577
1.75e-59	FFCP PHASE2:Hg19::chr1:198636234..198636246,-	p2@ENST00000413577
2.81e-57	FFCP PHASE2:Hg19::chr15:33180558..33180570,-	p9@FMN1
2.81e-57	FFCP PHASE1:Hg19::chr15:33180558..33180570,-	p9@FMN1
2.16e-56	FFCP PHASE2:Hg19::chr14:38371323..38371347,-	p1@ENST00000554257, p1@uc001wuk.1
2.16e-56	FFCP PHASE1:Hg19::chr14:38371323..38371347,-	p1@ENST00000554257, p1@uc001wuk.1
4.55e-54	FFCP PHASE1:Hg19::chr1:197886421..197886432,+	p2@LHX9
4.55e-54	FFCP PHASE2:Hg19::chr1:197886421..197886432,+	p2@LHX9
1.36e-53	FFCP PHASE1:Hg19::chr14:32963433..32963487,+	p4@AKAP6
1.36e-53	FFCP PHASE2:Hg19::chr14:32963433..32963487,+	p4@AKAP6
1.37e-52	FFCP PHASE1:Hg19::chr1:198636401..198636419,-	p3@ENST00000413577
1.37e-52	FFCP PHASE2:Hg19::chr1:198636401..198636419,-	p3@ENST00000413577
5.26e-49	FFCP PHASE1:Hg19::chr12:88813132..88813143,-	p@chr12:88813132..88813143, -
5.26e-49	FFCP PHASE2:Hg19::chr12:88813132..88813143,-	p@chr12:88813132..88813143, -
7.25e-49	FFCP PHASE1:Hg19::chr1:197886646..197886657,+	p5@LHX9
7.25e-49	FFCP PHASE2:Hg19::chr1:197886646..197886657,+	p5@LHX9
8.98e-46	FFCP PHASE2:Hg19::chr6:140893217..140893243,-	p@chr6:140893217..140893243, -
8.98e-46	FFCP PHASE1:Hg19::chr6:140893217..140893243,-	p@chr6:140893217..140893243, -
3.79e-45	FFCP PHASE2:Hg19::chr5:167087144..167087148,-	p1@ENST00000522956
3.79e-45	FFCP PHASE1:Hg19::chr5:167087144..167087148,-	p1@ENST00000522956
2.97e-44	FFCP PHASE2:Hg19::chr3:58021410..58021424,+	p@chr3:58021410..58021424, +
2.97e-44	FFCP PHASE1:Hg19::chr3:58021410..58021424,+	p@chr3:58021410..58021424, +
1.0e-42	FFCP PHASE2:Hg19::chr21:28336890..28336913,-	p@chr21:28336890..28336913, -
1.0e-42	FFCP PHASE1:Hg19::chr21:28336890..28336913,-	p@chr21:28336890..28336913, -
1.22e-42	FFCP PHASE1:Hg19::chr1:115782479..115782490,+	p@chr1:115782479..115782490, +
1.22e-42	FFCP PHASE2:Hg19::chr1:115782479..115782490,+	p@chr1:115782479..115782490, +
1.99e-42	FFCP PHASE2:Hg19::chr6:113697400..113697411,-	p@chr6:113697400..113697411, -
1.99e-42	FFCP PHASE1:Hg19::chr6:113697400..113697411,-	p@chr6:113697400..113697411, -
2.44e-42	FFCP PHASE1:Hg19::chr1:197886665..197886732,+	p3@LHX9
2.44e-42	FFCP PHASE2:Hg19::chr1:197886665..197886732,+	p3@LHX9
2.91e-42	FFCP PHASE2:Hg19::chr8:23564380..23564391,+	p1@ENST00000523874
2.91e-42	FFCP PHASE1:Hg19::chr8:23564380..23564391,+	p1@ENST00000523874
2.41e-40	FFCP PHASE2:Hg19::chr17:1936721..1936751,+	p3@DPH1
2.41e-40	FFCP PHASE1:Hg19::chr17:1936721..1936751,+	p3@DPH1
1.09e-39	FFCP PHASE2:Hg19::chr6:113697548..113697566,-	p@chr6:113697548..113697566, -
1.09e-39	FFCP PHASE1:Hg19::chr6:113697548..113697566,-	p@chr6:113697548..113697566, -
1.11e-38	FFCP PHASE2:Hg19::chr5:167181769..167181798,+	p17@ODZ2
1.11e-38	FFCP PHASE1:Hg19::chr5:167181769..167181798,+	p17@ODZ2
2.23e-38	FFCP PHASE2:Hg19::chr2:239778648..239778664,+	p@chr2:239778648..239778664, +
2.23e-38	FFCP PHASE1:Hg19::chr2:239778648..239778664,+	p@chr2:239778648..239778664, +
2.45e-38	FFCP PHASE1:Hg19::chr18:52969844..52969895,-	p27@TCF4
2.45e-38	FFCP PHASE2:Hg19::chr18:52969844..52969895,-	p27@TCF4
2.79e-38	FFCP PHASE2:Hg19::chr12:51986236..51986261,-	p@chr12:51986236..51986261, -
2.79e-38	FFCP PHASE1:Hg19::chr12:51986236..51986261,-	p@chr12:51986236..51986261, -
4.55e-38	FFCP PHASE2:Hg19::chr1:197889151..197889159,+	p@chr1:197889151..197889159, +
4.55e-38	FFCP PHASE1:Hg19::chr1:197889151..197889159,+	p@chr1:197889151..197889159, +
6.71e-38	FFCP PHASE2:Hg19::chr5:167148342..167148357,+	p1@ENST00000517346
6.71e-38	FFCP PHASE1:Hg19::chr5:167148342..167148357,+	p1@ENST00000517346
7.92e-38	FFCP PHASE2:Hg19::chr2:36784074..36784084,-	p@chr2:36784074..36784084, -
7.92e-38	FFCP PHASE1:Hg19::chr2:36784074..36784084,-	p@chr2:36784074..36784084, -
1.37e-37	FFCP PHASE2:Hg19::chr7:84122019..84122030,-	p18@SEMA3A
1.37e-37	FFCP PHASE1:Hg19::chr7:84122019..84122030,-	p18@SEMA3A
4.82e-37	FFCP PHASE2:Hg19::chr7:84121947..84121959,-	p12@SEMA3A
4.82e-37	FFCP PHASE1:Hg19::chr7:84121947..84121959,-	p12@SEMA3A
7.5e-37	FFCP PHASE2:Hg19::chr6:140985056..140985096,-	p@chr6:140985056..140985096, -
7.5e-37	FFCP PHASE1:Hg19::chr6:140985056..140985096,-	p@chr6:140985056..140985096, -
3.48e-36	FFCP PHASE2:Hg19::chr5:127873659..127873667,-	p12@FBN2
3.48e-36	FFCP PHASE1:Hg19::chr5:127873659..127873667,-	p12@FBN2
4.93e-36	FFCP PHASE2:Hg19::chr9:132472174..132472192,+	p@chr9:132472174..132472192, +
4.93e-36	FFCP PHASE1:Hg19::chr9:132472174..132472192,+	p@chr9:132472174..132472192, +
5.38e-36	FFCP PHASE2:Hg19::chr12:88801610..88801614,-	p@chr12:88801610..88801614, -
5.38e-36	FFCP PHASE1:Hg19::chr12:88801610..88801614,-	p@chr12:88801610..88801614, -
6.14e-36	FFCP PHASE1:Hg19::chr19:43690649..43690663,-	p2@PSG5
6.14e-36	FFCP PHASE2:Hg19::chr19:43690649..43690663,-	p2@PSG5
6.47e-36	FFCP PHASE1:Hg19::chr1:240256439..240256449,-	p@chr1:240256439..240256449, -
6.47e-36	FFCP PHASE2:Hg19::chr1:240256439..240256449,-	p@chr1:240256439..240256449, -
1.33e-35	FFCP PHASE1:Hg19::chr1:240448610..240448624,+	p@chr1:240448610..240448624, +
1.33e-35	FFCP PHASE2:Hg19::chr1:240448610..240448624,+	p@chr1:240448610..240448624, +
1.4e-35	FFCP PHASE1:Hg19::chr12:88813089..88813098,-	p@chr12:88813089..88813098, -
1.4e-35	FFCP PHASE2:Hg19::chr12:88813089..88813098,-	p@chr12:88813089..88813098, -
1.9e-35	FFCP PHASE2:Hg19::chr18:52969674..52969685,-	p24@TCF4
1.9e-35	FFCP PHASE1:Hg19::chr18:52969674..52969685,-	p24@TCF4
2.59e-35	FFCP PHASE2:Hg19::chr11:26210383..26210402,+	p2@ENST00000531798
2.59e-35	FFCP PHASE1:Hg19::chr11:26210383..26210402,+	p2@ENST00000531798
4.99e-35	FFCP PHASE1:Hg19::chr9:81628797..81628811,+	p@chr9:81628797..81628811, +
4.99e-35	FFCP PHASE2:Hg19::chr9:81628797..81628811,+	p@chr9:81628797..81628811, +
5.16e-35	FFCP PHASE1:Hg19::chr15:33180439..33180446,-	p@chr15:33180439..33180446, -
5.16e-35	FFCP PHASE2:Hg19::chr15:33180439..33180446,-	p@chr15:33180439..33180446, -
8.83e-35	FFCP PHASE2:Hg19::chr4:127876558..127876592,-	p1@ENST00000515428
8.83e-35	FFCP PHASE1:Hg19::chr4:127876558..127876592,-	p1@ENST00000515428
1.85e-34	FFCP PHASE2:Hg19::chr8:19171231..19171238,+	p7@SH2D4A
1.85e-34	FFCP PHASE1:Hg19::chr8:19171231..19171238,+	p7@SH2D4A
2.29e-34	FFCP PHASE2:Hg19::chr11:121972578..121972593,-	p3@ENST00000530955
2.29e-34	FFCP PHASE1:Hg19::chr11:121972578..121972593,-	p3@ENST00000530955

Showing 1 to 100 of 100 entries